z-logo
Premium
Nucleotides. Part LVI. Synthesis and biological activity of modified (2′–5′)triadenylates containing 2′‐terminal 2′,3′‐dideoxy‐3′‐fluoroadenosine derivatives
Author(s) -
Kvasyuk Evgeny I.,
Kulak Tamara I.,
Tkachenko Olga V.,
Sentyureva Svetlana L.,
Mikhailopulo Igor A.,
Suhadolnik Robert J.,
Henderson Earl E.,
Horvath Susan E.,
Guan MingXu,
Pfleiderer Wolfgang
Publication year - 1998
Publication title -
helvetica chimica acta
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.74
H-Index - 82
eISSN - 1522-2675
pISSN - 0018-019X
DOI - 10.1002/hlca.19980810538
Subject(s) - chemistry , trimer , nucleotide , stereochemistry , phosphodiesterase , terminal (telecommunication) , biochemistry , organic chemistry , enzyme , dimer , gene , telecommunications , computer science
Some new (2′–5′)triadenylates 13 – 16 , containing at the 2′‐terminal end 3′‐fluoro‐2′,3′‐dideoxyadenosine derivatives, have been synthesized by the phosphotriester method. The selectively blocked nucleosides 2 , 4 , 5 , and 7 , were synthesized from the corresponding unprotected nucleosides 1 , 3 , and 6 . The synthesized trimers 13 , and 14 were 4‐ and 8‐fold, respectively, more stable towards phosphodiesterase from Crotalus durissus than the natural trimer 17 . In comparison to trimer 17 the new compounds 13 – 15 inhibit HIV‐1 reverse transcriptase (RT) activity, and 15 and 16 the HIV‐1 induced syncytia formation 2–3 fold whereas none of 13 – 16 can improve R Nase L activity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom